Latest Share Purchase Plan News

Orion Minerals has raised approximately A$5.8 million through a share placement and loan conversions, while launching a Share Purchase Plan targeting an additional A$4 million to fund key copper projects.

EQ Resources has successfully raised A$4 million through a strongly supported placement to fund expansion and optimization at its Mt Carbine tungsten mine, reinforcing its position amid global supply challenges.

QPM Energy Limited has launched a $2 million Share Purchase Plan at $0.031 per share, matching a recent $10 million placement, to support the development of its Isaac Energy Hub. Eligible shareholders in Australia and New Zealand can participate until mid-July.

TruScreen Group Limited has corrected an administrative error in its Share Purchase Plan allocations, ensuring shareholders receive their proper pro-rata entitlements ahead of a key special meeting.

S2 Resources has closed its Share Purchase Plan significantly oversubscribed, prompting a pro-rata scale back. The combined funds from the SPP and recent placement will accelerate exploration across multiple Australian projects.

Aguia Resources has successfully closed its Share Purchase Plan, raising approximately $649,200 through the issuance of over 18 million new shares. This capital injection supports the company’s phosphate and gold projects in Brazil and Colombia.

Blackstone Minerals has raised $22.6 million through a heavily oversubscribed placement led by Macquarie Bank, fueling a major drilling program at its Mankayan Copper-Gold Project in the Philippines. The capital raise follows a transformative merger and signals strong institutional confidence in the company’s growth strategy.

Prescient Therapeutics has opened a Share Purchase Plan to raise up to $7 million, offering shareholders discounted shares to fund the Phase 2 development of its targeted cancer therapy PTX-100.

Staude Capital Global Value Fund Limited (GVF) has responded to ASX concerns over a media article revealing details of its capital raising before official announcement, denying any direct media disclosures and reaffirming its compliance policies.

Prescient Therapeutics has launched a $7 million Share Purchase Plan at a notable discount to fund the next phase of clinical trials for its promising PTX-100 cancer therapy. The capital raise aims to accelerate progress toward regulatory approval and patient access.

Duxton Farms has increased its placement to $4.55 million, issuing over 3.6 million new shares to fund the acquisition of four Australian agriculture companies. This move aims to fast-track the company’s diversification and growth strategy in the agricultural investment sector.

QPM Energy Limited has launched the Isaac Energy Hub with its first stage, a 112MW gas-fired power station, aiming for mid-2027 commissioning. The company is raising $12 million to support project development and expand its integrated energy utility footprint.